Kimco Realty (KIM)
NYSEReal EstateReit - RetailSnapshot 2026-07-07
Reading KIM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KIM free→NYSEReal EstateReit - RetailSnapshot 2026-07-07
Reading KIM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KIM free→QuarterlyIQ Insights · KIM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $25.29. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $25, KIM's earnings are too small for P/E to mean much; on sales it trades at 64× p/ffo (4.8× the 13× p/ffo peer median). At a normal multiple the price implies ~24% near-term growth vs our ~4% forecast. That gap is an optionality premium a financial-multiple model can't price — our $20 fair value covers only the as-is business, low confidence. Analysts target $25–$29. Note: our $20 fair value sits below the entire analyst range ($25–$29). Even valued only for durable growth at sustainable margins, it's worth about $27 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$25.00 – $29.00 (median $28.00) · 7 analysts · as of 2026-06-29
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2020-Q1, 2020-Q2, 2020-Q3, 2020-Q4
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $28.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $12.03 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $5.63 | — | — | TTM | high |
| graham number | 12M | $16.48 | — | — | TTM | high |
| Mgmt guidance | 12M | $10.84 | 13.2 | 0.82 | Mgmt | high |
| Peer P/FCF | 12M | $27.00 | 23.3 | 1.16 | TTM | high |
| Peer P/FFO | 12M | $5.22 | 13.2 | 0.39 | TTM | high |
| Peer P/S | 12M | $25.29 | 7.9 | 3.21 | TTM | high |
| PEG | 12M | $14.42 | 18.7 | 0.77 | TTM | high |
| residual income | 12M | $13.38 | — | — | TTM | high |
| Own P/E history | 12M | $24.23 | 31.5 | 0.77 | TTM | high |
| triangulated | 12M | $10.33 | 13.2 | 0.78 | Triangulated | high |
| Mgmt guidance | 3Y | $13.75 | 13.2 | 1.04 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $21.14 | 23.3 | 0.91 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $28.16 | 7.9 | 3.58 | Analyst | medium |
| PEG | 3Y | $19.76 | 18.7 | 1.06 | Analyst | medium |
| Own P/E history | 3Y | $33.20 | 31.5 | 1.06 | Analyst | medium |
| Mgmt guidance | 5Y | $16.11 | 13.2 | 1.22 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $17.96 | 23.3 | 0.77 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $30.21 | 7.9 | 3.84 | Analyst | high |
| PEG | 5Y | $21.20 | 18.7 | 1.13 | Analyst | high |
| Own P/E history | 5Y | $35.62 | 31.5 | 1.13 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.